QualTek Molecular Laboratories
 Call us: 215-504-7402
HomeOur VisionAbout QualTekIHC ServicesApplied IHCNewsCareers

PD-L1 in Various Tumors
PD-L1 Testing
QualTek developed and validated a PD-L1 IHC assay in over 20 different tumor indications and has tested thousands of clinical samples, including those for prospective enrollment. 
 
QualTek has experience with several  PD-L1 antibodies and can also incorporate staining for correlatives (such as PD-1, CD3, CD4, CD8 and FoxP3) in mono or combination trials.

Head and Neck Cancer
Non Small Cell Lung Carcinoma
Non Small Cell Lung Carcinoma
Non Small Cell Lung Carcinoma
Melanoma
Melanoma